Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1983 Jan;38(1):22–24. doi: 10.1136/thx.38.1.22

Intrapleural Corynebacterium parvum for malignant pleural effusions.

R Felletti, C Ravazzoni
PMCID: PMC459478  PMID: 6845257

Abstract

A pilot study of topical (intrapleural) treatment with Corynebacterium parvum was carried out in 10 patients with malignant pleural effusions complicating primary or secondary neoplasms and necessitating frequent thoracocentesis for symptomatic relief. The method was aspiration of all intrapleural fluid except a small portion left for dilution, and then injection of 7 mg of a preparation of Corynebacterium parvum suspended in 20 ml of normal saline solution. The treatment was repeated in each case as clinical conditions called for further thoracocentesis. In eight of these 10 patients the treatment resulted in prompt reduction of the rate of accumulation of pleural fluid and a striking change of cell sediment composition, with appreciable reduction in or complete disappearance of malignant cells and a rise in lymphocyte and neutrophil polymorph counts. The best responders were patients with primary pleural mesothelioma. Clinical improvement was evident in all responders.

Full text

PDF
22

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOTSFORD T. W. EXPERIENCES WITH RADIOACTIVE COLLOIDAL GOLD IN THE TREATMENT OF PLEURAL EFFUSION CAUSED BY METASTATIC CANCER OF THE BREAST. N Engl J Med. 1964 Mar 12;270:552–555. doi: 10.1056/NEJM196403122701103. [DOI] [PubMed] [Google Scholar]
  2. Bayly T. C., Kisner D. L., Sybert A., Macdonald J. S., Tsou E., Schein P. S. Tetracycline and quinacrine in the control of malignant pleural effusions. A randomized trial. Cancer. 1978 Mar;41(3):1188–1192. doi: 10.1002/1097-0142(197803)41:3<1188::aid-cncr2820410357>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  3. Desai S. D., Figueredo A. Intracavitary doxorubicin in malignant effusions. Lancet. 1979 Apr 21;1(8121):872–872. doi: 10.1016/s0140-6736(79)91282-0. [DOI] [PubMed] [Google Scholar]
  4. Israël L., Halpern B. Le Corynebacterium parvum dans les cancers avancés. Premiére évaluation de l'activité thérapeutique de cette immuno-stimuline. Nouv Presse Med. 1972 Jan 1;1(1):19–23. [PubMed] [Google Scholar]
  5. Jones G. R. Treatment of recurrent malignant pleural effusion by iodized talc pleurodesis. Thorax. 1969 Jan;24(1):69–73. doi: 10.1136/thx.24.1.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. MARK J. B., GOLDENBERG I. S., MONTAGUE A. C. INTRAPLEURAL MECHLORETHAMINE HYDROCHLORIDE THERAPY FOR MALIGNANT PLEURAL EFFUSION. JAMA. 1964 Mar 14;187:858–860. doi: 10.1001/jama.1964.03060240066022. [DOI] [PubMed] [Google Scholar]
  7. Mantovani A., Sessa C., Peri G., Allavena P., Introna M., Polentarutti N., Mangioni C. Intraperitoneal administration of Corynebacterium parvum in patients with ascitic ovarian tumors resistant to chemotherapy: effects on cytotoxicity of tumor-associated macrophages and NK cells. Int J Cancer. 1981;27(4):437–446. doi: 10.1002/ijc.2910270404. [DOI] [PubMed] [Google Scholar]
  8. Millar J. W., Hunter A. M., Horne N. W. Intrapleural immunotherapy with Corynebacterium parvum in recurrent malignant pleural effusions. Thorax. 1980 Nov;35(11):856–858. doi: 10.1136/thx.35.11.856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Serrou B., Cupissol D. Epanchements pleuraux. Traitement local par Corynebacterium parvum. Nouv Presse Med. 1980 Jun 7;9(25):1777–1778. [PubMed] [Google Scholar]
  10. Stiksa G., Korsgaard R., Simonsson B. G. Treatment of recurrent pleural effusion by pleurodesis with quinacrine. Comparison between instillation by repeated thoracenteses and by tube drainage. Scand J Respir Dis. 1979 Aug;60(4):197–205. [PubMed] [Google Scholar]
  11. Tattersall M. H., Fox R. M., Newlands E. S., Woods R. L. Intracavitary doxorubicin in malignant effusions. Lancet. 1979 Feb 17;1(8112):390–390. doi: 10.1016/s0140-6736(79)92937-4. [DOI] [PubMed] [Google Scholar]
  12. Thatcher N., Lamb B., Swindell R., Crowther D. Effects of Corynebacterium parvum on cellular immunity of cancer patients, assayed sequentially over 63 days. Cancer. 1981 Jan 15;47(2):285–290. doi: 10.1002/1097-0142(19810115)47:2<285::aid-cncr2820470213>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  13. Webb H. E., Oaten S. W., Pike C. P. Treatment of malignant ascitic and pleural effusion with Corynebacterium parvum. Br Med J. 1978 Feb 11;1(6109):338–340. doi: 10.1136/bmj.1.6109.338. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES